Rachel Zeig-Owens1,2,3, Ankura Singh1,2, Thomas K Aldrich2, Charles B Hall4, Theresa Schwartz1,2, Mayris P Webber1,3, Hillel W Cohen3, Kerry J Kelly1, Anna Nolan1,5,6, David J Prezant1,2, Michael D Weiden1,5,6. 1. 1 The Bureau of Health Services and Office of Medical Affairs, Fire Department of the City of New York, Brooklyn, New York. 2. 2 Division of Pulmonary Medicine, Department of Medicine, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York. 3. 3 Division of Epidemiology and. 4. 4 Division of Biostatistics, Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York; and. 5. 5 Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, and. 6. 6 Department of Environmental Medicine, New York University School of Medicine, New York, New York.
Abstract
RATIONALE: Rescue/recovery work at the World Trade Center disaster site (WTC) caused a proximate decline in lung function in Fire Department of the City of New York firefighters. A subset of this cohort experienced an accelerated rate of lung function decline over 15 years of post-September 11, 2001 (9/11) follow-up. OBJECTIVES: To determine if early postexposure blood leukocyte concentrations are biomarkers for subsequent FEV1 decline and incident airflow limitation. METHODS: Individual rates of forced expiratory volume in 1 second (FEV1) change were calculated for 9,434 firefighters using 88,709 spirometric measurements taken between September 11, 2001, and September 10, 2016. We categorized FEV1 change rates into three trajectories: accelerated FEV1 decline (FEV1 loss >64 ml/yr), expected FEV1 decline (FEV1 loss between 0 and 64 ml/yr), and improved FEV1 (positive rate of change >0 ml/yr). Occurrence of FEV1/FVC less than 0.70 after 9/11 defined incident airflow limitation. Using regression models, we assessed associations of post-9/11 blood eosinophil and neutrophil concentrations with subsequent FEV1 decline and airflow limitation, adjusted for age, race, smoking, height, WTC exposure level, weight change, and baseline lung function. RESULTS: Accelerated FEV1 decline occurred in 12.7% of participants (1,199 of 9,434), whereas post-9/11 FEV1 improvement occurred in 8.3% (780 of 9,434). Higher blood eosinophil and neutrophil concentrations were each associated with accelerated FEV1 decline after adjustment for covariates (odds ratio [OR], 1.10 per 100 eosinophils/μl; 95% confidence interval [CI], 1.05-1.15; and OR, 1.10 per 1,000 neutrophils/μl; 95% CI, 1.05-1.15, respectively). Multivariable-adjusted linear regression models showed that a higher blood neutrophil concentration was associated with a faster rate of FEV1 decline (1.14 ml/yr decline per 1,000 neutrophils/μl; 95% CI, 0.69-1.60 ml/yr; P < 0.001). Higher blood eosinophil concentrations were associated with a faster rate of FEV1 decline in ever-smokers (1.46 ml/yr decline per 100 eosinophils/μl; 95% CI, 0.65-2.26 ml/yr; P < 0.001) but not in never-smokers (P for interaction = 0.004). Higher eosinophil concentrations were also associated with incident airflow limitation (adjusted hazard ratio, 1.10 per 100 eosinophils/μl; 95% CI, 1.04-1.15). Compared with the expected FEV1 decline group, individuals experiencing accelerated FEV1 decline were more likely to have incident airflow limitation (adjusted OR, 4.12; 95% CI, 3.30-5.14). CONCLUSIONS: Higher post-9/11 blood neutrophil and eosinophil concentrations were associated with subsequent accelerated FEV1 decline in WTC-exposed firefighters. Both higher blood eosinophil concentrations and accelerated FEV1 decline were associated with incident airflow limitation in WTC-exposed firefighters.
RATIONALE: Rescue/recovery work at the World Trade Center disaster site (WTC) caused a proximate decline in lung function in Fire Department of the City of New York firefighters. A subset of this cohort experienced an accelerated rate of lung function decline over 15 years of post-September 11, 2001 (9/11) follow-up. OBJECTIVES: To determine if early postexposure blood leukocyte concentrations are biomarkers for subsequent FEV1 decline and incident airflow limitation. METHODS: Individual rates of forced expiratory volume in 1 second (FEV1) change were calculated for 9,434 firefighters using 88,709 spirometric measurements taken between September 11, 2001, and September 10, 2016. We categorized FEV1 change rates into three trajectories: accelerated FEV1 decline (FEV1 loss >64 ml/yr), expected FEV1 decline (FEV1 loss between 0 and 64 ml/yr), and improved FEV1 (positive rate of change >0 ml/yr). Occurrence of FEV1/FVC less than 0.70 after 9/11 defined incident airflow limitation. Using regression models, we assessed associations of post-9/11 blood eosinophil and neutrophil concentrations with subsequent FEV1 decline and airflow limitation, adjusted for age, race, smoking, height, WTC exposure level, weight change, and baseline lung function. RESULTS: Accelerated FEV1 decline occurred in 12.7% of participants (1,199 of 9,434), whereas post-9/11 FEV1 improvement occurred in 8.3% (780 of 9,434). Higher blood eosinophil and neutrophil concentrations were each associated with accelerated FEV1 decline after adjustment for covariates (odds ratio [OR], 1.10 per 100 eosinophils/μl; 95% confidence interval [CI], 1.05-1.15; and OR, 1.10 per 1,000 neutrophils/μl; 95% CI, 1.05-1.15, respectively). Multivariable-adjusted linear regression models showed that a higher blood neutrophil concentration was associated with a faster rate of FEV1 decline (1.14 ml/yr decline per 1,000 neutrophils/μl; 95% CI, 0.69-1.60 ml/yr; P < 0.001). Higher blood eosinophil concentrations were associated with a faster rate of FEV1 decline in ever-smokers (1.46 ml/yr decline per 100 eosinophils/μl; 95% CI, 0.65-2.26 ml/yr; P < 0.001) but not in never-smokers (P for interaction = 0.004). Higher eosinophil concentrations were also associated with incident airflow limitation (adjusted hazard ratio, 1.10 per 100 eosinophils/μl; 95% CI, 1.04-1.15). Compared with the expected FEV1 decline group, individuals experiencing accelerated FEV1 decline were more likely to have incident airflow limitation (adjusted OR, 4.12; 95% CI, 3.30-5.14). CONCLUSIONS: Higher post-9/11 blood neutrophil and eosinophil concentrations were associated with subsequent accelerated FEV1 decline in WTC-exposed firefighters. Both higher blood eosinophil concentrations and accelerated FEV1 decline were associated with incident airflow limitation in WTC-exposed firefighters.
Authors: Thomas K Aldrich; Madeline Vossbrinck; Rachel Zeig-Owens; Charles B Hall; Theresa M Schwartz; William Moir; Mayris P Webber; Hillel W Cohen; Anna Nolan; Michael D Weiden; Vasilios Christodoulou; Kerry J Kelly; David J Prezant Journal: Chest Date: 2016-01-13 Impact factor: 9.410
Authors: Thomas K Aldrich; Jackson Gustave; Charles B Hall; Hillel W Cohen; Mayris P Webber; Rachel Zeig-Owens; Kaitlyn Cosenza; Vasilios Christodoulou; Lara Glass; Fairouz Al-Othman; Michael D Weiden; Kerry J Kelly; David J Prezant Journal: N Engl J Med Date: 2010-04-08 Impact factor: 91.245
Authors: John R Hurst; Jørgen Vestbo; Antonio Anzueto; Nicholas Locantore; Hana Müllerova; Ruth Tal-Singer; Bruce Miller; David A Lomas; Alvar Agusti; William Macnee; Peter Calverley; Stephen Rennard; Emiel F M Wouters; Jadwiga A Wedzicha Journal: N Engl J Med Date: 2010-09-16 Impact factor: 91.245
Authors: Emily S Wan; Weiliang Qiu; Andrea Baccarelli; Vincent J Carey; Helene Bacherman; Stephen I Rennard; Alvar Agusti; Wayne Anderson; David A Lomas; Dawn L Demeo Journal: Hum Mol Genet Date: 2012-04-06 Impact factor: 6.150
Authors: Bushra Naveed; Michael D Weiden; Sophia Kwon; Edward J Gracely; Ashley L Comfort; Natalia Ferrier; Kusali J Kasturiarachchi; Hillel W Cohen; Thomas K Aldrich; William N Rom; Kerry Kelly; David J Prezant; Anna Nolan Journal: Am J Respir Crit Care Med Date: 2011-11-17 Impact factor: 21.405
Authors: Henrik Watz; Kay Tetzlaff; Emiel F M Wouters; Anne Kirsten; Helgo Magnussen; Roberto Rodriguez-Roisin; Claus Vogelmeier; Leonardo M Fabbri; Pascal Chanez; Ronald Dahl; Bernd Disse; Helen Finnigan; Peter M A Calverley Journal: Lancet Respir Med Date: 2016-04-07 Impact factor: 30.700
Authors: Sophia Kwon; Barbara Putman; Jessica Weakley; Charles B Hall; Rachel Zeig-Owens; Theresa Schwartz; Brianne Olivieri; Ankura Singh; Maryann Huie; Debra Morrison; Mayris P Webber; Hillel W Cohen; Kerry J Kelly; Thomas K Aldrich; Anna Nolan; David J Prezant; Michael R Shohet; Michael D Weiden Journal: Ann Am Thorac Soc Date: 2016-08
Authors: Klaus F Rabe; Suzanne Hurd; Antonio Anzueto; Peter J Barnes; Sonia A Buist; Peter Calverley; Yoshinosuke Fukuchi; Christine Jenkins; Roberto Rodriguez-Roisin; Chris van Weel; Jan Zielinski Journal: Am J Respir Crit Care Med Date: 2007-05-16 Impact factor: 21.405
Authors: Dana B Hancock; Mark Eijgelsheim; Jemma B Wilk; Sina A Gharib; Laura R Loehr; Kristin D Marciante; Nora Franceschini; Yannick M T A van Durme; Ting-Hsu Chen; R Graham Barr; Matthew B Schabath; David J Couper; Guy G Brusselle; Bruce M Psaty; Cornelia M van Duijn; Jerome I Rotter; André G Uitterlinden; Albert Hofman; Naresh M Punjabi; Fernando Rivadeneira; Alanna C Morrison; Paul L Enright; Kari E North; Susan R Heckbert; Thomas Lumley; Bruno H C Stricker; George T O'Connor; Stephanie J London Journal: Nat Genet Date: 2009-12-13 Impact factor: 41.307
Authors: Wassim W Labaki; Lucas M Kimmig; Gökhan M Mutlu; MeiLan K Han; Surya P Bhatt Journal: Am J Respir Crit Care Med Date: 2019-06-15 Impact factor: 21.405
Authors: Barbara Putman; Lies Lahousse; Ankura Singh; Rachel Zeig-Owens; Charles B Hall; Melissa J Fazzari; Theresa Schwartz; Mayris P Webber; Hillel W Cohen; David J Prezant; Michael D Weiden Journal: Ann Am Thorac Soc Date: 2020-06
Authors: Ankura Singh; Charles Liu; Barbara Putman; Rachel Zeig-Owens; Charles B Hall; Theresa Schwartz; Mayris P Webber; Hillel W Cohen; Kenneth I Berger; Anna Nolan; David J Prezant; Michael D Weiden Journal: Chest Date: 2018-07-17 Impact factor: 9.410
Authors: Gabriele Grunig; Nedim Durmus; Yian Zhang; Yuting Lu; Sultan Pehlivan; Yuyan Wang; Kathleen Doo; Maria L Cotrina-Vidal; Roberta Goldring; Kenneth I Berger; Mengling Liu; Yongzhao Shao; Joan Reibman Journal: Int J Environ Res Public Health Date: 2022-07-01 Impact factor: 4.614
Authors: Rafael E de la Hoz; Moshe Shapiro; Anna Nolan; Juan C Celedón; Jaime Szeinuk; Roberto G Lucchini Journal: Respir Med Date: 2020-06-07 Impact factor: 3.415
Authors: Charles Liu; Barbara Putman; Ankura Singh; Rachel Zeig-Owens; Charles B Hall; Theresa Schwartz; Mayris P Webber; Hillel W Cohen; Melissa J Fazzari; David J Prezant; Michael D Weiden Journal: Int J Environ Res Public Health Date: 2019-05-13 Impact factor: 3.390
Authors: Sophia Kwon; George Crowley; Mena Mikhail; Rachel Lam; Emily Clementi; Rachel Zeig-Owens; Theresa M Schwartz; Mengling Liu; David J Prezant; Anna Nolan Journal: Int J Environ Res Public Health Date: 2019-04-26 Impact factor: 3.390
Authors: Michael D Weiden; Ankura Singh; David G Goldfarb; Barbara Putman; Rachel Zeig-Owens; Theresa Schwartz; Hillel W Cohen; David J Prezant Journal: Am J Ind Med Date: 2021-07-20 Impact factor: 3.079